John Dahldorf

Benvenue Medical, Inc. engages int the provision and development of invasive systems for spine repair. It offers Kiva an implant solution for vertebral augmentation and a departure from balloon kyphoplasty, Blazer-C a vertebral augmentation system that utilizes a unique cannulated curved wire offering mechanical channel creation, and Luna a interbody implant that is delivered through a minimally-invasive cannula to the disc space and expands in-situ. The company was founded by Laurent B. Schaller in 2004 and is headquartered in Santa Clara, CA.

Volcano Corp. designs, develops and manufactures a broad suite of intravascular ultrasound products. The company was founded by Olav B. Bergheim and Samuel Ward Casscells and is headquartered in San Diego, CA.

Volcano Corp. is a privately held medical device company founded in 2001. With over 400 worldwide employees, Volcano is focused on the discovery, development and commercialization of products for the detection and treatment of atherosclerosis and vulnerable plaques in the coronary and peripheral vascular systems. Volcano products include Intravascular Ultrasound (IVUS) systems and catheters, as well as physiology guide wires. With global distribution, VOLCANO is a leading provider of innovative diagnostic and therapy-guiding technologies to the interventional cardiology and peripheral vascular fields.

Harmony Foods Corp. manufactures confectionery delivery systems. The firm offers gelatin, pectin and starch gummies, combination confections, jelly beans, sours balls, gelatin, pectin, starch gummies, and combination confections. The company was founded in 1968 and is headquartered in Santa Cruz, CA.

Fyodor Biotechnologies, Inc. is a healthcare company based in Baltimore, MD. Fyodor Biotechnologies has developed the Urine Malaria Test (UMT), which is the first and only non-blood test that tells in minutes if a fever is malaria, using a few drops of urine. The UMT is a disruptive innovation for malaria testing backed by top-rate science, and validated in a highly acclaimed pivotal clinical trial. The company's goal is to make it possible to test or be tested for malaria fast, at home or at a healthcare facility, and be promptly treated with over-the-counter antimalarial medicine. The company was founded by Eddy C. Agbo, who has been the CEO since incorporation.